Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
Laboratory of America Dividend Announcement
• Laboratory of America announced a quarterly dividend of $0.72 per ordinary share which will be made payable on 2024-12-13. Ex dividend date: 2024-11-26
• Laboratory of America annual dividend for 2024 was $3.60
• Laboratory of America annual dividend for 2023 was $2.88
• Laboratory of America's trailing twelve-month (TTM) dividend yield is 1.18%
• Laboratory of America's payout ratio for the trailing twelve months (TTM) is 56.05%
Laboratory of America Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-26 | $0.72 | quarterly | 2024-12-13 |
2024-08-29 | $0.72 | quarterly | 2024-09-13 |
2024-05-28 | $0.72 | quarterly | 2024-06-12 |
2024-05-24 | $0.72 | quarterly | 2024-06-12 |
2024-02-26 | $0.72 | quarterly | 2024-03-13 |
2023-11-07 | $0.72 | quarterly | 2023-12-12 |
2023-08-07 | $0.72 | quarterly | 2023-09-08 |
2023-05-17 | $0.72 | quarterly | 2023-06-08 |
2023-02-22 | $0.72 | quarterly | 2023-03-13 |
2022-11-16 | $0.72 | quarterly | 2022-12-09 |
2022-08-17 | $0.72 | quarterly | 2022-09-09 |
2022-05-18 | $0.72 | quarterly | 2022-06-09 |
1994-03-29 | $0.08 | quarterly | 1994-04-26 |
1993-12-29 | $0.08 | quarterly | 1994-01-25 |
1993-09-29 | $0.08 | quarterly | 1993-10-26 |
1993-06-29 | $0.08 | quarterly | 1993-07-27 |
1993-03-31 | $0.08 | quarterly | 1993-04-27 |
1992-12-29 | $0.08 | quarterly | 1993-01-26 |
1992-09-28 | $0.08 | quarterly | 1992-10-23 |
1992-06-26 | $0.08 | quarterly | 1992-07-23 |
1992-03-31 | $0.07 | quarterly | 1992-04-27 |
1992-01-06 | $0.07 | quarterly | 1992-01-31 |
1991-09-30 | $0.07 | quarterly | 1991-10-27 |
1991-06-27 | $0.07 | quarterly | 1991-07-24 |
1991-04-04 | $0.06 | quarterly | 1991-04-29 |
1990-12-31 | $0.06 | quarterly | 1991-01-28 |
Laboratory of America Dividend per year
Laboratory of America Dividend growth
Laboratory of America Dividend Yield
Laboratory of America current trailing twelve-month (TTM) dividend yield is 1.18%. Interested in purchasing Laboratory of America stock? Use our calculator to estimate your expected dividend yield:
Laboratory of America Financial Ratios
Laboratory of America Dividend FAQ
Other factors to consider when evaluating Laboratory of America as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Laboratory of America stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Laboratory of America's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Laboratory of America publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Laboratory of America distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Laboratory of America are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Laboratory of America sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Laboratory of America distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Laboratory of America declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Laboratory of America's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Laboratory of America's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.